HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TIMM8A
translocase of inner mitochondrial membrane 8A
Chromosome X Β· Xq22.1
NCBI Gene: 1678Ensembl: ENSG00000126953.8HGNC: HGNC:11817UniProt: A0A2R8YDA8
84PubMed Papers
21Diseases
0Drugs
24Pathogenic Variants
FUNCTIONAL ROLE
Transporter
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
mitochondrionmitochondrial intermembrane spacemitochondrial intermembrane space chaperone complexidentical protein bindingdeafness dystonia syndromeMohr-Tranebjaerg syndromehearing losseye disease
✦AI Summary

TIMM8A encodes a mitochondrial intermembrane space chaperone protein essential for importing multi-pass transmembrane proteins into the mitochondrial inner membrane 1. The protein protects hydrophobic precursors from aggregation and guides them through the intermembrane space, with the TIMM8-TIMM13 complex mediating import of proteins like TIMM23 and SLC25A12/ARALAR1 1. Loss-of-function mutations in TIMM8A cause Mohr-Tranebjaerg syndrome (MTS), a rare X-linked neurodegenerative disorder typically characterized by progressive hearing loss, dystonia, and visual impairment 12. However, clinical presentation shows variability, with some patients presenting dystonia and basal ganglia iron deposition without hearing loss 2. Mechanistically, TIMM8A mutations lead to mitochondrial dysfunction including reduced complex IV activity, decreased ATP synthesis, increased ROS generation, and mitochondrial fragmentation 1. The pathogenesis involves downstream reduction of CHCHD2, another mitochondrial protein essential for homeostasis, which can rescue the dysfunction when overexpressed 1. Beyond neurological disease, TIMM8A is overexpressed in various cancers, particularly breast cancer, where it correlates with poor prognosis and promotes proliferation, migration, and invasion through NF-ΞΊB signaling activation 34.

Sources cited
1
TIMM8A is a mitochondrial intermembrane space chaperone that imports transmembrane proteins and its mutations cause mitochondrial dysfunction in MTS
PMID: 40075073
2
TIMM8A mutations cause Mohr-Tranebjaerg syndrome with variable clinical presentation including dystonia without hearing loss
PMID: 40597358
3
TIMM8A overexpression in breast cancer promotes proliferation and invasion through NF-ΞΊB signaling
PMID: 40419670
4
TIMM8A upregulation in breast cancer correlates with poor prognosis and immune infiltration
PMID: 36248992
⚠Limited data available β€” This gene has 4 indexed publications. Summary and analysis may be incomplete.
Disease Associationsβ“˜21
deafness dystonia syndromeOpen Targets
0.77Strong
Mohr-Tranebjaerg syndromeOpen Targets
0.77Strong
hearing lossOpen Targets
0.37Weak
eye diseaseOpen Targets
0.37Weak
genetic disorderOpen Targets
0.30Weak
auditory neuropathyOpen Targets
0.27Weak
breast cancerOpen Targets
0.10Weak
lung cancerOpen Targets
0.07Suggestive
metabolic syndromeOpen Targets
0.07Suggestive
cancerOpen Targets
0.07Suggestive
osteoarthritis, kneeOpen Targets
0.07Suggestive
Young adult-onset ParkinsonismOpen Targets
0.06Suggestive
Primary dystonia, DYT13 typeOpen Targets
0.06Suggestive
essential tremorOpen Targets
0.06Suggestive
spinocerebellar ataxia type 15/16Open Targets
0.06Suggestive
Spinocerebellar ataxia type 40Open Targets
0.06Suggestive
torsion dystonia 2Open Targets
0.06Suggestive
Hereditary late-onset Parkinson diseaseOpen Targets
0.05Suggestive
dystonia 27Open Targets
0.05Suggestive
spinocerebellar ataxia type 20Open Targets
0.05Suggestive
Mohr-Tranebjaerg syndromeUniProt
Pathogenic Variants24
NM_004085.4(TIMM8A):c.127T>C (p.Cys43Arg)Likely pathogenic
Deafness dystonia syndrome|Inborn genetic diseases
β˜…β˜…β˜†β˜†2019β†’ Residue 43
NM_004085.4(TIMM8A):c.58C>T (p.Gln20Ter)Pathogenic
Deafness dystonia syndrome
β˜…β˜†β˜†β˜†2026β†’ Residue 20
NM_004085.4(TIMM8A):c.217dup (p.Thr73fs)Pathogenic
Deafness dystonia syndrome
β˜…β˜†β˜†β˜†2025β†’ Residue 73
NM_004085.4(TIMM8A):c.153_223dup (p.Gln75delinsLeuGlyGlnSerTrpThrValGlyLeuArgProValLeuTer)Pathogenic
Deafness dystonia syndrome
β˜…β˜†β˜†β˜†2025β†’ Residue 75
NM_004085.4(TIMM8A):c.133-1G>APathogenic
Deafness dystonia syndrome
β˜…β˜†β˜†β˜†2025
NM_004085.4(TIMM8A):c.28del (p.Ala10fs)Pathogenic
Deafness dystonia syndrome
β˜…β˜†β˜†β˜†2025β†’ Residue 10
NM_004085.4(TIMM8A):c.132G>A (p.Trp44Ter)Pathogenic
Deafness dystonia syndrome|Papillary renal cell carcinoma type 1
β˜…β˜†β˜†β˜†2025β†’ Residue 44
NM_004085.4(TIMM8A):c.112C>T (p.Gln38Ter)Pathogenic
Deafness dystonia syndrome|not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 38
NM_004085.4(TIMM8A):c.148_157del (p.Lys50fs)Pathogenic
Deafness dystonia syndrome
β˜…β˜†β˜†β˜†2023β†’ Residue 50
NM_004085.4(TIMM8A):c.73del (p.Glu24_Val25insTer)Pathogenic
Deafness dystonia syndrome|not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 24
NM_004085.4(TIMM8A):c.181del (p.Ala61fs)Pathogenic
Deafness dystonia syndrome
β˜…β˜†β˜†β˜†2022β†’ Residue 61
NM_004085.4(TIMM8A):c.198C>G (p.Cys66Trp)Likely pathogenic
Deafness dystonia syndrome
β˜…β˜†β˜†β˜†2020β†’ Residue 66
NM_004085.4(TIMM8A):c.133-1G>TPathogenic
not provided|Thyroid cancer, nonmedullary, 1
β˜…β˜†β˜†β˜†2020
NC_000023.11:g.101345283_101347393delPathogenic
Deafness dystonia syndrome
β˜†β˜†β˜†β˜†2021
NM_004085.4(TIMM8A):c.66_67del (p.Ile23fs)Pathogenic
Deafness dystonia syndrome
β˜†β˜†β˜†β˜†2021β†’ Residue 23
NM_004085.4(TIMM8A):c.70G>T (p.Glu24Ter)Pathogenic
Deafness dystonia syndrome
β˜†β˜†β˜†β˜†2016β†’ Residue 24
NM_004085.4(TIMM8A):c.100C>T (p.Gln34Ter)Likely pathogenic
not provided
β˜†β˜†β˜†β˜†2016β†’ Residue 34
NM_004085.4(TIMM8A):c.127del (p.Cys43fs)Pathogenic
Deafness dystonia syndrome
β˜†β˜†β˜†β˜†2006β†’ Residue 43
NM_004085.4(TIMM8A):c.133-23A>CPathogenic
Deafness dystonia syndrome
β˜†β˜†β˜†β˜†2005
NC_000023.11:g.(?_101345661)_(101348742_?)delPathogenic
Deafness dystonia syndrome
β˜†β˜†β˜†β˜†2004
View on ClinVar β†—
Related Genes
TOMM7Protein interaction100%TIMM23Protein interaction99%SLC25A12Protein interaction97%SLC25A13Protein interaction96%CHCHD4Protein interaction94%TOMM40Protein interaction93%
Tissue Expression6 tissues
Liver
100%
Heart
80%
Brain
70%
Bone Marrow
47%
Ovary
37%
Lung
30%
Gene Interaction Network
Click a node to explore
TIMM8ATOMM7TIMM23SLC25A12SLC25A13CHCHD4TOMM40
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt O60220
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.93LoF Tolerant
pLIβ“˜
0.55Intermediate
Observed/Expected LoF0.30 [0.12–0.93]
RankingsWhere TIMM8A stands among ~20K protein-coding genes
  • #5,702of 20,598
    Most Researched84
  • #2,017of 5,498
    Most Pathogenic Variants24
  • #8,592of 17,882
    Most Constrained (LOEUF)0.93
Genes detectedTIMM8A
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
CHCHD2 rescues the mitochondrial dysfunction in iPSC-derived neurons from patient with Mohr-Tranebjaerg syndrome.
PMID: 40075073
Cell Death Dis Β· 2025
1.00
2
The oncogenic role of TIMM8A in cancer and the mechanistic insights into the function in breast cancer cells.
PMID: 40419670
Sci Rep Β· 2025
0.90
3
Upregulation of TIMM8A is correlated with prognosis and immune regulation in BC.
PMID: 36248992
Front Oncol Β· 2022
0.80
4
Mutation spectrum of hearing loss patients in Northwest China: Identification of 20 novel variants.
PMID: 38860500
Mol Genet Genomic Med Β· 2024
0.70
5
TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy.
PMID: 36207751
World J Surg Oncol Β· 2022
0.60